Clinical Trial Update: Improvement of EPO-resistance in Hemodialysis Patients With Chronic Inflammation by High Cut-off Hemodialysis [NA]

View source ↗

Summary

A completed clinical trial evaluating whether high cut-off hemodialysis improves erythropoietin resistance in patients with end-stage renal disease and chronic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Snippet

Sponsor: Vantive Health LLC | Conditions: End-Stage Renal Disease (ESRD) | NA | Status: COMPLETED